Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other Working Capital Changes (2016 - 2025)

Mimedx's Other Working Capital Changes history spans 14 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 138.75% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $641000.0, down 42.36%, while the annual FY2025 figure was $641000.0, 42.36% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was $1.4 million at Mimedx, up from -$615000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $3.1 million in Q4 2023 and bottomed at -$8.0 million in Q4 2021.
  • The 5-year median for Other Working Capital Changes is -$231500.0 (2021), against an average of -$405500.0.
  • The largest annual shift saw Other Working Capital Changes crashed 5200.0% in 2021 before it soared 207.17% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$8.0 million in 2021, then skyrocketed by 135.51% to $2.8 million in 2022, then rose by 9.55% to $3.1 million in 2023, then crashed by 80.99% to $591000.0 in 2024, then surged by 138.75% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Other Working Capital Changes are $1.4 million (Q4 2025), -$615000.0 (Q3 2025), and -$854000.0 (Q2 2025).